Reduced Blood-Brain Barrier Expression of Fatty-Acid Binding Protein 5 is associated with Increased Vulnerability of APP/PS1 mice to Cognitive Deficits from Low Omega-3 Fatty Acid Diets.
JOURNAL OF NEUROCHEMISTRY(2018)
摘要
Lower levels of the cognitively beneficial docosahexaenoic acid (DHA) are often observed in Alzheimer's disease (AD) brains. Brain DHA levels are regulated by the blood-brain barrier (BBB) transport of plasma-derived DHA, a process facilitated by fatty acid-binding protein 5 (FABP5). This study reports a 42.112.6% decrease in the BBB transport of C-14-DHA in 8-month-old AD transgenic mice (APPswe,PSEN1E9) relative to wild-type mice, associated with a 34.5 +/- 6.7% reduction in FABP5 expression in isolated brain capillaries of AD mice. Furthermore, short-term spatial and recognition memory deficits were observed in AD mice on a 6-month n-3 fatty acid-depleted diet, but not in AD mice on control diet. This intervention led to a dramatic reduction (41.5 +/- 11.9%) of brain DHA levels in AD mice. This study demonstrates FABP5 deficiency and impaired DHA transport at the BBB are associated with increased vulnerability to cognitive deficits in mice fed an n-3 fatty acid-depleted diet, in line with our previous studies demonstrating a crucial role of FABP5 in BBB transport of DHA and cognitive function.
更多查看译文
关键词
Alzheimer's disease,blood-brain barrier,cognitive function,docosahexaenoic acid,fatty acid-binding protein,omega-3 fatty acids
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要